PURA Home State Of Texas Opens For Business On Friday

Dallas, TX -- April 28, 2020 -- InvestorsHub NewsWire -- Puration, Inc. (USOTC: PURA) today released a supplementary update to its fifth weekly Coronavirus Market update. PURA is headquartered in Texas and notably, last night, Texas Governor Greg Abott announced the statewide shelter in place order will end this Thursday, April 30^th and that Texas will be open for business on Friday, May 1^st. Governor Abbot outlined specific guidelines for business to follow on reopening in order avoid creating any need for a future shelter in place.

The Texas economic reopening is exciting and anticipated to bode well for PURA. Nevertheless, management still anticipates the Coronavirus Pandemic to create both issues and opportunities during and after the crisis. Management plans to carefully continue to evaluate potential issues and opportunities and maintain publishing weekly updates in order to provide stakeholders with the most current information and insight into management thinking throughout this highly fluid business environment.

So far, the impact to PURA has been minimal. PURA was fortunate enough to execute a production run of its primary revenue generator, EVERx CBD Sports Water, just prior to the shutdown and now, with light at the end of the tunnel, it appears PURA will make it through to the reopening of the economy with its current inventory.

PURA continues with its acquisition campaign launched earlier this year. PURA recently announced initiating three new due diligence efforts resulting from new opportunities that management attributes to the impact of the Coronavirus economic situation on businesses in general. Puration’s CEO, Brian Shibley, plans to publish an update later this week on PURA’s ongoing acquisition campaign highlighting the company’s patented CBD extraction process patent.

PURA management continues to advance a prompt publishing of the annual financial report for 2019. The company filed an extension in conjunction with the current Covid-19 extension parameters and plans to publish its financial report before the deadline for the current extension parameters.
For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350